Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ACR:AU

0.8650 AUD 0.0500 6.13%

As of 02:10:26 ET on 04/17/2015.

Snapshot for Acrux Ltd (ACR)

Open: 0.8200 Day's Range: 0.8150 - 0.8650 Volume: 795,240
Previous Close: 0.8150 52wk Range: 0.7500 - 2.1000 1-Yr Rtn: -46.20%

Stock Chart for ACR

No chart data available.
  • ACR:AU 0.8650
  • 1D
  • 1M
  • 1Y
0.8150
Interactive ACR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACR

Current P/E Ratio (ttm) 14.2975
Estimated P/E(06/2015) 10.1765
Relative P/E vs. AS51 0.7231
Earnings Per Share (AUD) (ttm) 0.0605
Est. EPS (AUD) (06/2015) 0.0850
Est. PEG Ratio -
Market Cap (M AUD) 144.04
Shares Outstanding (M) 166.52
30 Day Average Volume 845,862
Price/Book (mrq) 4.0288
Price/Sale (ttm) 6.2188
Dividend Indicated Gross Yield 13.21%
Cash Dividend (AUD) 0.0800
Dividend Ex-Date 09/04/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/21/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACR

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for ACR

Acrux Limited is a specialty pharmaceutical company that develops a range of healthcare products for the global market. The Company develops transdermal drug delivery systems. The Company's products include hormone products for women's health, anti-aging skin care and haircare products as well as veterinary pharmaceutical products. The company is a Pooled Development Fund.

Ross DobinsonChairman/FounderMichael John KotsanisCEO/Managing Director
Sharon PapworthCFO/SecretaryNina WebsterDirector:Commercial
More Company Profile & Key Executives for ACR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil